Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on safety, tolerability, pharmacokinetics and anti-tumor activity of AC0010 in advanced Non-Small Cell Lung Cancer across Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AC0010

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN